Clinical trial for Epilepsy
Official title Healthy Aging in People With Epilepsy Program
ClinicalTrials.gov ID: NCT06052605
What this study is testing
- What it's testing
- The study will see if teaching about dementia, chronic disease, and lifestyle changes improves knowledge and quality of life for older adults with epilepsy.
- Who it's for
- Older adults who have epilepsy and are interested in learning about dementia and healthy aging.
- What's involved
- Participants are split into two groups. Those in the intervention group attend a 12‑week group education program. All participants complete surveys before and after the program to measure changes in knowledge and quality of life.
- Time commitment
- The program lasts 12 weeks, with group sessions and pre‑ and post‑program surveys. Participants in the intervention group attend the weekly sessions; all participants complete the surveys at the start and end of the study.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 to 90. Healthy volunteers may be eligible.
You may be able to join if
- Current diagnosis of epilepsy made by a neurologist, epileptologist, or internist/family medicine physician
- Age 55 years or older
- Proficiency in English (self-assessed)
- Healthcare professional in the US who is involved in the clinical care or treatment of individuals with epilepsy (including Epilepsy Foundation...
- Current diagnosis of epilepsy made by a neurologist, epileptologist, or internist/family medicine physician
You likely can't join if
- Evidence of Dementia (based on phone cognitive screener; those with suspected mild cognitive impairment will not be excluded)
- Age 90 years or older
- Evidence of Dementia (based on phone cognitive screener; those with suspected mild cognitive impairment will not be excluded)
- Age 90 years or older
See the full eligibility criteria
- Current diagnosis of epilepsy made by a neurologist, epileptologist, or internist/family medicine physician
- Age 55 years or older
- Proficiency in English (self-assessed)
- Healthcare professional in the US who is involved in the clinical care or treatment of individuals with epilepsy (including Epilepsy Foundation organizational leaders)
- Current diagnosis of epilepsy made by a neurologist, epileptologist, or internist/family medicine physician
- Age 55 years or older (up to 90)
- Proficiency in English (self-assessed)
- Evidence of Dementia (based on phone cognitive screener; those with suspected mild cognitive impairment will not be excluded)
- Age 90 years or older
- Evidence of Dementia (based on phone cognitive screener; those with suspected mild cognitive impairment will not be excluded)
- Age 90 years or older
The study team makes the final eligibility decision.
Where it is enrolling
- Cleveland, Ohio, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years to 90 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Cleveland, Ohio, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.